Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$428K Sell
22,495
-11,817
-34% -$228K ﹤0.01% 1529
2025
Q4
$562K Sell
34,312
-2,591
-7% -$45.6K 0.01% 1369
2025
Q3
$693K Buy
+36,903
New +$662K 0.01% 1240
2024
Q4
Sell
-12,275
Closed -$220K 2005
2024
Q3
$220K Sell
12,275
-5,503
-31% -$100K ﹤0.01% 1780
2024
Q2
$313K Sell
17,778
-37,286
-68% -$770K ﹤0.01% 1561
2024
Q1
$1.41M Sell
55,064
-3,826
-6% -$96K 0.02% 794
2023
Q4
$1.54M Sell
58,890
-1,178
-2% -$26.9K 0.02% 706
2023
Q3
$1.38M Buy
+60,068
New +$1.51M 0.02% 709

Other funds holding XP

Atria Investments's XP Position: Q1 2026 in Review

Atria Investments reduced its XP (XP) stake by 34% in Q1 2026, selling an estimated $228K and leaving 22,495 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Atria Investments first reported a position in XP in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.54M in Q4 2023. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Atria Investments held 22,495 shares of XP worth $428K as of Q1 2026.
  • Atria Investments sold 11,817 XP shares in Q1 2026, an estimated $228K.
  • XP made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1529 holding.
  • Atria Investments first reported a position in XP in Q3 2023 and has held it in 8 quarters since.
  • Atria Investments's XP position peaked at $1.54M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.